TECHBio-Techne

SPX

Data as of Oct 15, 2026 · 09:38 p.m.

$72.52

+0.03%

Unlock full analysis
53/100
● Neutral Zone

No directional signal

The canonical InvestCompass profile currently shows mixed evidence without a clear directional edge.

Global score threshold

Buy Zone ≥ 80
Partial Buy Zone ≥ 65
Neutral Zone ≥ 45
Partial Sell Zone ≥ 25
Sell Zone < 25

Bio-Techne

TECH
Market
SPX
Sector:
Healthcare
Industry
Biotechnology

About the company

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. Its Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Global score detail

Breakdown of the 4 modules in the global score (Macro, Sector, Fundamental, Technical)

1. Macro(15%)57/100
Sector(30%)45/100
Fundamental(25%)69/100
Technical(30%)47/100
Macro — Full analysis workspace
Fundamental — Full analysis workspace
Sector — Full analysis workspace
Technical — Full analysis workspace
Fundamentals and peer comparison
Signals and trade plan

Current Price

$72.52

Period High

$72.69

Period Low

$43.02

Analyst Target

$70.50

-2.8% upside

Price history

Loading chart...

Moving averages
Technical indicators
Technical indicators
Technical indicators
Technical indicators
Moving averages
Technical indicators
AI and news commentary
AI and news commentary

InvestCompass provides analysis tools, not financial advice. Data may be delayed.

TECH: Bio-Techne stock analysis | InvestCompass